JMIR Ment Health. 2017 Sep 29;4(3):e38. doi: 10.2196/mental.6713.
Effectiveness of Optional Videoconferencing-Based Treatment of Alcohol Use Disorders: Randomized Controlled Trial.
JMIR mental health
Kristine Tarp, Anders Bo Bojesen, Anna Mejldal, Anette Søgaard Nielsen
Affiliations
Affiliations
- Unit of Clinical Alcohol Research, Department of Clinical Research, University of Southern Denmark, Odense C, Denmark.
- Centre for Telepsychiatry, Department of Psychiatry, Region of Southern Denmark, Odense C, Denmark.
PMID: 28963093
PMCID: PMC5640821 DOI: 10.2196/mental.6713
Abstract
BACKGROUND: Treatment of alcohol use disorders (AUDs) is characterized by an adherence rate below 50%. Clinical research has found that patient adherence enhances treatment effect; hence, health authorities, clinicians, and researchers strive to explore initiatives contributing to patients receiving treatment. Concurrently, videoconferencing-based treatment is gaining ground within other addiction and psychiatric areas.
OBJECTIVE: The aim of this study was to test whether optional videoconferencing increases adherence to and effectiveness of AUD treatment in a randomized controlled trial (RCT). We hypothesized that the intervention would decrease premature dropout (the primary outcome), as well as increase successful treatment termination, treatment duration, and treatment outcome (secondary outcomes).
METHODS: We conducted this study in the public outpatient alcohol clinic in Odense, Denmark, between September 2012 and April 2013. It was an RCT with 2 groups: treatment as usual (TAU) and treatment as usual with add-on intervention (TAU+I). The TAU+I group had the option, from session to session, to choose to receive treatment as usual via videoconferencing. Data consisted of self-reported responses to the European version of the Addiction Severity Index (EuropASI). We collected data at baseline, at follow-up at 3, 6, and 12 months, and at discharge.
RESULTS: Among consecutive patients attending the clinic, 128 met the inclusion criteria, and 71 of them were included at baseline. For the primary outcome, after 180 days, 2 of 32 patients (6%) in the TAU+I group and 12 of 39 patients (31%) in the TAU group had dropped out prematurely. The difference is significant (P=.008). After 365 days, 8 patients (25%) in the TAU+I group and 17 patients (44%) in the TAU group had dropped out prematurely. The difference is significant (P=.02). For the secondary outcomes, significantly more patients in the TAU+I group were still attending treatment after 1 year (P=.03). We found no significant differences between the 2 groups with regard to successful treatment termination and treatment outcome.
CONCLUSIONS: The results indicate that offering patients optional videoconferencing may prevent premature dropouts from treatment and prolong treatment courses. However, the small sample size precludes conclusions regarding the effect of the intervention, which was not detectable in the patients' use of alcohol and severity of problems.
TRIAL REGISTRATION: The Regional Health Research Ethics Committee System in Denmark: S-20110052; https://komite.regionsyddanmark.dk/wm258128 (Archived by WebCite at http://www.webcitation.org/6tTL3CO6u).
©Kristine Tarp, Anders Bo Bojesen, Anna Mejldal, Anette Søgaard Nielsen. Originally published in JMIR Mental Health (http://mental.jmir.org), 29.09.2017.
Keywords: adherence; alcoholism; effectiveness; patient compliance; patient dropouts; premature dropout; treatment of alcohol use disorders; videoconferencing
References
- Psychol Serv. 2012 Aug;9(3):298-309 - PubMed
- Drug Alcohol Depend. 2015 Sep 1;154:117-24 - PubMed
- Addict Sci Clin Pract. 2015 Mar 07;10:7 - PubMed
- J Nerv Ment Dis. 1998 Dec;186(12):752-60 - PubMed
- Int J Methods Psychiatr Res. 2008 Jun;17 Suppl 1:S50-9 - PubMed
- Drug Alcohol Depend. 1994 Feb;34(3):201-9 - PubMed
- Addict Sci Clin Pract. 2015 May 28;10:14 - PubMed
- Drug Alcohol Depend. 2007 May 11;88(2-3):138-45 - PubMed
- J Rural Health. 2014 Fall;30(4):422-32 - PubMed
- Annu Rev Psychol. 2001;52:685-716 - PubMed
- J Nerv Ment Dis. 1980 Jan;168(1):26-33 - PubMed
- Addict Disord Their Treat. 2017 Jun;16(2):70-79 - PubMed
- Acta Psychiatr Scand. 2007 Jun;115(6):420-33 - PubMed
- J Stud Alcohol Drugs. 2009 Jul;70(4):516-27 - PubMed
- J Med Internet Res. 2011 Dec 31;13(4):e126 - PubMed
- J Clin Psychol. 1999 Feb;55(2):171-80; discussion 191-200 - PubMed
- Drug Alcohol Depend. 2008 Nov 1;98(1-2):63-9 - PubMed
- JMIR Ment Health. 2016 Feb 09;3(1):e9 - PubMed
- Ann Epidemiol. 2007 Sep;17 (9):643-53 - PubMed
- Psychol Addict Behav. 2013 Dec;27(4):1159-66 - PubMed
- Lancet. 1993 Oct 9;342(8876):909-13 - PubMed
- J Subst Abuse Treat. 2000 Mar;18(2):129-35 - PubMed
- J Telemed Telecare. 2000;6(3):147-51 - PubMed
- Addict Behav. 2005 Mar;30(3):415-22 - PubMed
- Behav Res Ther. 2011 Mar;49(3):158-69 - PubMed
- BMC Psychiatry. 2016 Dec 5;16(1):432 - PubMed
- BMC Psychiatry. 2014 Dec 14;14:355 - PubMed
- J Nerv Ment Dis. 2000 Feb;188(2):101-7 - PubMed
- J Telemed Telecare. 2005;11(7):372-5 - PubMed
- J Subst Abuse Treat. 1992;9(3):199-213 - PubMed
- Med Law. 1997;16(3):607-20 - PubMed
- Psychother Psychosom. 2011;80(6):325-8 - PubMed
- Lancet. 1996 Jan 27;347(8996):237-40 - PubMed
Publication Types